[1] Iyer RV, Haynes PT, Schneider RF, et al.  Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and[Tc-99m]HL-91: Correlation with microelectrode measurements[J]. J Nucl Med, 2001, 42(2): 337-344.
[2] Siim BG, Laux WT, Rutland MD, et al.  Scintigraphic imaging of the hypoxia marker(99m)technetium-labeled 2, 2′-(1, 4-diaminobutane)bis(2-methyl-3-butanone)dioxime(99mTc-labeled HL-91; Prognox): noninvasive detection of tumor response to the antivas-cular agent 5, 6-dimethylxanthenone-4-acetic acid[J]. Cancer Res, 2000, 60(16): 4582-4588.
[3] Zhang X, Melo T, Ballinger JR, et al.  Studies of 99mTc-BnAO(HL-91): a non-nitroaromatic compound for hypoxic cell detection[J]. Int J Radiat Oncol Biol Phys, 1998, 42(4): 737-740.   doi: 10.1016/S0360-3016(98)00301-0
[4] Yutani K, Kusuoka H, Fukuchi K, et al.  Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia[J]. J Nucl Med, 1999, 40(5): 854-861.
[5] Ballinger JR.  Imaging hypoxia in tumors[J]. Semin Nucl Med, 2001, 31(4): 321-329.   doi: 10.1053/snuc.2001.26191
[6] Vaupel P, Kallinowski F, Okunieff P.  Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors[J]. Cancer Res, 1989, 49(23): 6449-6465.
[7] 高远红, 杨伟志, 徐国镇.  肿瘤乏氧问题的研究现状[J]. 国外医学肿瘤学分册, 1999, 26(5): 270-273.
[8] Okada, RD, Johnson, G, Nguyen, KN, et al.  HL-91-technetium-99m: a new marker of viability in ischemic myocardium[J]. J Nucl Cardiol, 1999, 6(3): 306-315.   doi: 10.1016/S1071-3581(99)90043-0
[9] Honess DJ, Hill SA, Collingridge DR, et al.  Preclinical evaluation of the novel hypoxic marker 99mTc-HL91(prognox)in murine and xenograft system in vivo[J]. Int J Radiat Oncol Biol Phys, 1998, 42(4): 731-.   doi: 10.1016/S0360-3016(98)00300-9